We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYAN
4751
DELISTED
Cyanotech Corp
CYAN
$1K ﹤0.01%
282
-2,224
-89% -$5.46K
SALM
4752
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
$1K ﹤0.01%
1,250
-17,370
-93% -$22.1K
LVOX
4753
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$1K ﹤0.01%
+99
New +$1K
HCDI
4754
DELISTED
Harbor Custom Development, Inc. Common Stock
HCDI
$1K ﹤0.01%
+5
New +$572
CGRN
4755
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$1K ﹤0.01%
+196
New +$814
SURF
4756
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$1K ﹤0.01%
+200
New +$1.21K
UBP
4757
DELISTED
Urstadt Biddle Properties Inc.
UBP
$1K ﹤0.01%
+96
New +$849
TESS
4758
DELISTED
Tessco Technologies Inc
TESS
$1K ﹤0.01%
123
-2,825
-96% -$17.5K
HEXO
4759
DELISTED
HEXO Corp. Common Shares
HEXO
$1K ﹤0.01%
22
-3,385
-99% -$135K
ACOR
4760
DELISTED
Acorda Therapeutics
ACOR
$1K ﹤0.01%
+12
New +$905
VNTR
4761
DELISTED
Venator Materials PLC
VNTR
$1K ﹤0.01%
559
-7,646
-93% -$14.9K
LOTZ
4762
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$1K ﹤0.01%
95
+93
+4,650% +$954
THCA
4763
DELISTED
Tuscan Holdings Corp. II Common Stock
THCA
$1K ﹤0.01%
+100
New +$1K
TMBR
4764
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
$1K ﹤0.01%
+19
New +$1.53K
HBP
4765
DELISTED
Huttig Building Products, Inc.
HBP
$1K ﹤0.01%
679
-4,105
-86% -$7.92K
CHPMU
4766
DELISTED
CHP Merger Corp. Unit
CHPMU
$1K ﹤0.01%
88
TLMD
4767
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$1K ﹤0.01%
97
-391
-80% -$4.03K
SCVX.U
4768
DELISTED
SCVX Corp. Units, each consisting of one Class A ordinary share, $0.0001 par value per share, and on
SCVX.U
$1K ﹤0.01%
+100
New +$1.07K
GSS
4769
DELISTED
Golden Star Resources Ltd.
GSS
$1K ﹤0.01%
184
+133
+261% +$553
TREB.U
4770
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
$1K ﹤0.01%
+47
New +$498
KSMTU
4771
DELISTED
Kismet Acquisition One Corp Unit
KSMTU
$1K ﹤0.01%
+100
New +$1K
SRACU
4772
DELISTED
Stable Road Acquisition Corp. Unit
SRACU
$1K ﹤0.01%
113
+101
+842% +$1.03K
ANDAU
4773
DELISTED
Andina Acquisition Corp. III Unit
ANDAU
$1K ﹤0.01%
100
+4
+4% +$44
APXTU
4774
DELISTED
Apex Technology Acquisition Corporation Unit
APXTU
$1K ﹤0.01%
90
GNRSU
4775
DELISTED
Greenrose Acquisition Corp. Unit
GNRSU
$1K ﹤0.01%
107
+7
+7% +$70

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.